Tablet
LINAGLIPTIN TAISHO TABLETS 5MG
Summary
LINAGLIPTIN TAISHO TABLETS 5MG — Tablet containing linagliptin. Hong Kong Registration No. HK-68588. Certificate Holder: TAISHO PHARMACEUTICAL (HK) LTD. Date of Registration: 26 Feb, 2025.
Product NameLINAGLIPTIN TAISHO TABLETS 5MG
Registration No.HK-68588
Certificate HolderTAISHO PHARMACEUTICAL (HK) LTD
Holder AddressUNIT 03, 25/F, GREENFIELD TOWER, CONCORDIA PLAZA, 1, SCIENCE MUSEUM ROAD, TSIM SHA TSUI, KOWLOON
Ingredientslinagliptin
Dosage FormTablet
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration26 Feb, 2025
ATC codesA10BH05
ATC Classification
ATC level 1
A Alimentary Tract and Metabolism
All ATC groupsA10
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。